Abstract:Introduction Cardiometabolic multimorbidity (CMM) and depression are risk factors for cognitive decline and dementia. We investigated the independent and synergistic associations of CMM and depression on longitudinal cognitive deterioration in two Asian cohorts of elderly at varying cognitive status with differed underlying neuropathology. Methods Eligible memory clinic (Harmonization) and stroke patients (Coast) aged ≥50 completed cognitive and clinical assessments at baseline and up to 5 follow-up visits in 6 years. Cardiometabolic diseases (CMDs), including hypertension, hyperlipidemia, diabetes mellitus, stroke and other cardiovascular diseases were assessed. Presence of CMM was defined as having two or more CMDs. Depression was defined by Geriatric Depression Scale (GDS) of ≥5. Biomarkers including cerebral beta-amyloid, cerebrovascular disease and ApoE genotype, were assessed by MRI and laboratory tests. Cognitive outcomes included cognitive trajectory patterns identified by the group-based trajectory model (GBTM) and the rate of change of global cognitive z-score. Multivariable logistic models and mixed models were conducted to assess the associations of CMM(+) and depression(+) with longitudinal cognitive decline. Stratification analysis by demographics and biomarkers was conducted. Results Among a total of 809 (Harmonization: 586, Coast: 223) participants, three cognitive trajectories were identified by the GBTM in each cohort. CMM(+) was independently associated with longitudinal cognitive decline. There was a significant interaction among CMM, depression and time with longitudinal cognition in both cohorts (ps of β(CMM*depression*time) < 0.05). Compared with reference group, CMM(+) and depression(+) were associated with patterns of rapid decline (OR=3.58, =95%CI=(1.64,7.81)) and slow decline (OR=3.32, 95%CI=(1.20,9.19)) in Harmonization, and decline/low stable (OR=4.01, 95%CI=(1.03,15.50)) in Coast. Participants with CMM(+) and depression(+) had a 0.24 (95%CI= -0.49, -0.01) and 0.13 (95%CI=-0.24,-0.01) units decline per year on global cognitive z-scores in Harmonization and Coast, respectively, compared with those with CMM(-) and depression(-). The combined effect between CMM and depression was more pronounced among older and male participants, as well as APOEε4 carriers. Discussion Our study demonstrated a synergistic effect between CMM and depression on longitudinal cognitive decline among elderly with differed underlying neuropathology. Targeting both CMM and depression in preventing cognitive decline may lead to greater effectiveness.

Association of depression and cognitive performance in US older adults: a secondary analysis of cross-sectional data using NHANES 2013-2014

Cognitive Performance Deficits Are Associated with Clinically Significant Depression Symptoms in Older US Adults

Association between early life circumstances and depressive symptoms among Chinese older adults: Results from China health and retirement longitudinal study Early life circumstances and depression

Late-life Depression and Cognitive Function among Older Adults in the US: the National Health and Nutrition Examination Survey, 2011-2014

Relationship between Cognitive Performance and Depressive Symptoms in Chinese Older Adults: The China Health and Retirement Longitudinal Study (CHARLS)

The Associations Between Cognitive Function and Depressive Symptoms among Older Chinese Population: A Cohort Study

Synergistic Effect of Cardiometabolic Multimorbidity and Depression on Longitudinal Cognitive Decline: Results from Two Longitudinal Asian Elderly Cohorts

Association Between Cognitive Decline and Depression in Middle-Aged and Older Adults: Findings from Six Large Cohorts in Different Countries

Association of depressive symptoms with decline of cognitive function—Rugao longevity and ageing study

Association Between Physical Performance and Cognitive Function in Chinese Community-Dwelling Older Adults: Serial Mediation of Malnutrition and Depression

Deprivation-related adverse childhood experiences and cognitive function among older adults: Mediating role of depression symptoms

Association of non-HDL-C and depression: a cross-sectional analysis of the NHANES data

Sex-specific in the association between depressive symptoms and risk of cognitive impairment in Chinese older adults

The association of depressive sarcopenia and cognitive decline among the elderly: Evidence from the Survey of Health and Retirement in Europe

Longitudinal association of depressive symptoms with cognition and neuroimaging biomarkers in cognitively unimpaired older adults, mild cognitive impairment, and Alzheimer's disease

Longitudinal Association of Depressive Symptoms with Cognition and Neuroimaging Biomarkers in Cognitively Unimpaired Older Adults, Mild Cognitive Impairment, and Alzheimer’s Disease

Association between depressive duration and cognitive decline in middle-aged and older adults: Evidence from the Health and Retirement Study 2010–2018

Depression Trajectories, Genetic Risk, and Cognitive Performance in Older Adults: Multilevel Model with a 10-Year Longitudinal Cohort

Independent and combined associations of depression and cognitive impairment with frailty in oldest-old adults

The association between self-rated health, number of family members, and cognitive function in community-dwelling older adults: Mediating role of depression

Depressive Symptoms and Cognitive Decline Among Chinese Rural Elderly Individuals: A Longitudinal Study With 2-Year Follow-Up